AbbVie Total Liabilities 2010-2025 | ABBV

AbbVie total liabilities for the quarter ending March 31, 2025 were $134.703B, a 4.35% decline year-over-year.

  • AbbVie total liabilities for 2024 were $131.797B, a 6.02% increase from 2023.
  • AbbVie total liabilities for 2023 were $124.314B, a 2.3% increase from 2022.
  • AbbVie total liabilities for 2022 were $121.518B, a 7.3% decline from 2021.

AbbVie Total Liabilities 2010-2025 | ABBV

  • AbbVie total liabilities for 2024 were $131.797B, a 6.02% increase from 2023.
  • AbbVie total liabilities for 2023 were $124.314B, a 2.3% increase from 2022.
  • AbbVie total liabilities for 2022 were $121.518B, a 7.3% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B